TAPDI OKSIJEN OZEL SAGLIK VE EGITIM HIZMETLERI SANAYI TICARET A.S.
BBIST:TNZTP22.94
TRY
-0.26
(-1.12%)
ISIN
TRETAPD00019
Return %
Stock
S&P 500
1Y
6.20
14.20
3Y
25.55
81.12
5Y
- -
68.34
Capital Structure
TRY
•
in mil. unless spec.Working Capital
TRY
•
in mil. unless spec.Growth Rates
TRY
•
in mil. unless spec.Quarterly Revenue
TRY
•
in mil. unless spec.Quarterly Earnings Per Share
TRY
•
in mil. unless spec.Quarterly Dividends Per Share
TRY
•
in mil. unless spec.Company Description
- Sector
- Health services
- Industry
- Medical/Nursing services
- Address
- Buca Turkey
- IPO Date
- Jan 11, 2023
- Website
- tinaztepe.com
- Similar Companies
- Business
- Tapdi Oksijen Ozel Saglik ve Egitim Hizmetleri Sanayi Ticaret A.S. is a Turkey-based healthcare and education services provider that operates comprehensive multi-specialty hospital networks, outpatient clinics, and specialized diagnostic centers under the Tinaztepe Health Group brand. Founded in 1999 and headquartered in Izmir, Turkey, the company delivers integrated inpatient and outpatient clinical services across a wide spectrum of therapeutic fields. Its primary healthcare offerings include cardiovascular surgery; cardiology; medical and radiation oncology; orthopedics and traumatology; neurology and neurosurgery; general surgery; obstetrics and gynecology; pediatrics; internal medicine; ophthalmology; urology; physical medicine and rehabilitation; adult, coronary, cardiovascular, and neonatal intensive care units; emergency medical services; advanced medical imaging and radiology; and clinical biochemistry, microbiology, and pathology laboratory services. The company operates major medical campuses across the Izmir metropolitan region, including Tinaztepe Buca Hospital, Tinaztepe Torbali Hospital, Tinaztepe Galen Hospital in Bayrakli, and associated outpatient medical centers, while catering to international patients through dedicated medical tourism programs. In addition to clinical care, the company supports academic and vocational healthcare training programs through its affiliations with Izmir Tinaztepe University. In recent developments, the company completed its initial public offering on Borsa Istanbul under the ticker symbol TNZTP, accelerated capital investments in solar energy generation projects to fulfill the electricity demands of its healthcare facilities sustainably, broadened its international patient network across Europe and the Middle East, and expanded its clinical capacity through modernizations of diagnostic imaging infrastructure and specialized surgical suites.